首页> 外国专利> DERIVATIVES OF 1,2,3,4,7,8-HEXAHIDRO-6H- (1,4) DIAZEPINO (6,7,1-IJ) QUINOLINA AS ANTI-PSYCHOTIC AND ANTI-OBESITY AGENTS.

DERIVATIVES OF 1,2,3,4,7,8-HEXAHIDRO-6H- (1,4) DIAZEPINO (6,7,1-IJ) QUINOLINA AS ANTI-PSYCHOTIC AND ANTI-OBESITY AGENTS.

机译:1,2,3,4,7,8-六氢己基-6H-(1,4)地西平(6,7,1-IJ)喹诺酮类的衍生物作为抗精神病和抗肥胖药。

摘要

Compound of formula I in which: R 1 is hydrogen or alkyl of 1 to 6 carbon atoms; R2 and R3 are each independently hydrogen, hydroxy, alkyl of 1-6 carbon atoms, alkoxy of 1-6 carbon atoms, halogen, carboxamido, carboalkoxy of two to six carbon atoms, perfluoroalkyl of 1-6 atoms carbon, cyano, alkanesulfonamido of 1-6 carbon atoms, alkanesulfonyl of 1-6 carbon atoms, alkanamide of 1-6 carbon atoms, amino, alkylamino of 1-6 carbon atoms, dialkylamino of 1-6 atoms of carbon by alkyl moiety, perfluoroalkoxy of 1-6 carbon atoms, alkanoyloxy of 2 to 6 carbon atoms, alkanoyl of 2 to 6 carbon atoms, aroyl of 6 to 8 carbon atoms, aryl of 5 to 7 carbon atoms , a C6 to C13 alkylaryl group having 5 to 7 carbon atoms in the aryl moiety, a 5- to 7-membered heteroaryl group, or a 6 to 13-member alkylheteroaryl group having 5 to 7 members in the heteroaryl moiety ; wherein any R2 or R3 substituent having an aryl or heteroaryl moiety may be optionally substituted, in the aryl or heteroaryl moiety, with 1 to 3 substituents independently selected from a halogen atom, a C1-C6 alkyl group, or a group C1-C6 alkoxy; R4 and R5 are independently hydrogen or alkyl of 1 to 6 carbon atoms; or R4 and R5, taken together with the carbon atoms to which they are attached, form a cyclic moiety selected from a cycloalkane of 4 to 8 carbon atoms, cycloalkene of 4 to 8 carbon atoms, bicyclic alkane bridge of 5 to 10 carbon atoms, bicyclic bridge alkene of 5 to 10 carbon atoms, pyran or thiopyran, in which the sulfur atom is optionally oxidized to sulfoxide or sulfone; wherein the cyclic moiety formed by R4 and R5 may be optionally substituted with 1 to 3 substituents independently selected from a halogen atom, from a C1-C6 alkyl group, or from a C1-C8 alkoxy group; R6 and R7 are each independently hydrogen or alkyl of 1 to 6 carbon atoms; and n is 1 or 2; or a pharmaceutically acceptable salt thereof.
机译:式I的化合物,其中:R 1是氢或1-6个碳原子的烷基; R 2和R 3各自独立地是氢,羟基,1-6个碳原子的烷基,1-6个碳原子的烷氧基,卤素,羧酰胺基,两个至六个碳原子的碳烷氧基,1-6个碳原子的全氟烷基,氰基,烷烃磺酰胺基1-6个碳原子,1-6个碳原子的烷磺酰基,1-6个碳原子的烷酰胺,氨基,1-6个碳原子的烷基氨基,1-6个碳原子的烷基烷基的二烷基氨基,1-6个碳的全氟烷氧基原子,2至6个碳原子的烷酰氧基,2至6个碳原子的烷酰基,6至8个碳原子的芳酰基,5至7个碳原子的芳基,在芳基部分具有5至7个碳原子的C6至C13烷基芳基; 5至7元杂芳基,或在杂芳基部分中具有5至7元的6至13元烷基杂芳基;其中具有芳基或杂芳基部分的任何R2或R3取代基可以在芳基或杂芳基部分中被1-3个独立地选自卤素原子,C1-C6烷基或C1-C6烷氧基的取代基取代; R4和R5独立地是氢或1-6个碳原子的烷基;或R 4和R 5与它们所连接的碳原子一起形成选自4至8个碳原子的环烷烃,4至8个碳原子的环烯烃,5至10个碳原子的双环烷烃桥的环状部分, 5-10个碳原子的双环桥烯烃,吡喃或噻喃,其中硫原子任选地被氧化成亚砜或砜;其中由R4和R5形成的环状部分可以任选地被1-3个独立地选自卤素原子,C1-C6烷基或C1-C8烷氧基的取代基取代; R 6和R 7各自独立地是氢或1-6个碳原子的烷基; n为1或2;或其药学上可接受的盐。

著录项

  • 公开/公告号ES2282652T3

    专利类型

  • 公开/公告日2007-10-16

    原文格式PDF

  • 申请/专利权人 WYETH;

    申请/专利号ES20030747309T

  • 申请日2003-04-24

  • 分类号C07D471/06;A61K31/551;A61P1;A61P1/16;A61P3;A61P3/04;A61P3/10;A61P9;A61P9/12;A61P11;A61P15/08;A61P17;A61P19/02;A61P19/06;A61P25;A61P25/06;A61P25/08;A61P25/16;A61P25/18;A61P25/20;A61P25/22;A61P25/24;A61P25/28;A61P35;A61P43;

  • 国家 ES

  • 入库时间 2022-08-21 20:54:21

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号